Skip to content
10-Q

Quarterly Report

VOR BIOPHARMA INC. VOR

0001193125-25-280104

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 10.41M sh
Shares Diluted Q3 2025 · Sep 30, 2025 6.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 6.4M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 3.42M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 3.41M sh
Capex Q3 2025 · Sep 30, 2025 $627K
Capex Q3 2025 · Sep 30, 2024 $157K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$119.91M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$75.6M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $160.46M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $81.95M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $52.8M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$2.23B
Stockholders Equity Q3 2025 · Jun 30, 2025 −$1.51B
Stockholders Equity Q3 2025 · Mar 31, 2025 $66.07M
Stockholders Equity Q3 2025 · Dec 31, 2024 $96.66M
Stockholders Equity Q3 2025 · Sep 30, 2024 $72.96M
Stockholders Equity Q3 2025 · Jun 30, 2024 $98.08M
Stockholders Equity Q3 2025 · Mar 31, 2024 $123.04M
Stockholders Equity Q3 2025 · Dec 31, 2023 $150.72M
Current Liabilities Q3 2025 · Sep 30, 2025 $18.84M
Current Liabilities Q3 2025 · Dec 31, 2024 $18.61M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.4B
Total Liabilities Q3 2025 · Dec 31, 2024 $46.23M
Current Assets Q3 2025 · Sep 30, 2025 $172.49M
Current Assets Q3 2025 · Dec 31, 2024 $96.51M
Total Assets Q3 2025 · Sep 30, 2025 $176.24M
Total Assets Q3 2025 · Dec 31, 2024 $142.89M
Eps Diluted Q3 2025 · Sep 30, 2025 −$121.63
Eps Diluted Q3 2025 · Sep 30, 2025 −$378.11
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$8.05
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$25.25
Eps Basic Q3 2025 · Sep 30, 2025 −$121.63
Eps Basic Q3 2025 · Sep 30, 2025 −$378.11
Eps Basic restated Q3 2025 · Sep 30, 2024 −$8.05
Eps Basic restated Q3 2025 · Sep 30, 2024 −$25.25
Sga Expense Q3 2025 · Sep 30, 2025 $13.97M
Sga Expense Q3 2025 · Sep 30, 2025 $33.34M
Sga Expense Q3 2025 · Sep 30, 2024 $6.7M
Sga Expense Q3 2025 · Sep 30, 2024 $21.91M
Rd Expense Q3 2025 · Sep 30, 2025 $14.14M
Rd Expense Q3 2025 · Sep 30, 2025 $302.34M
Rd Expense Q3 2025 · Sep 30, 2024 $21.82M
Rd Expense Q3 2025 · Sep 30, 2024 $67.96M
Net Income Q3 2025 · Sep 30, 2025 −$812.68M
Net Income Q3 2025 · Sep 30, 2025 −$2.42B
Net Income Q3 2025 · Jun 30, 2025 −$1.57B
Net Income Q3 2025 · Mar 31, 2025 −$32.49M
Net Income Q3 2025 · Sep 30, 2024 −$27.56M
Net Income Q3 2025 · Sep 30, 2024 −$86.2M
Net Income Q3 2025 · Jun 30, 2024 −$27.84M
Net Income Q3 2025 · Mar 31, 2024 −$30.8M
Operating Income Q3 2025 · Sep 30, 2025 −$28.11M
Operating Income Q3 2025 · Sep 30, 2025 −$335.68M
Operating Income Q3 2025 · Sep 30, 2024 −$28.51M
Operating Income Q3 2025 · Sep 30, 2024 −$89.87M